News

Krystal Biotech announced the first patient has been dosed in EMERALD-1, its phase 1/2 clinical trial evaluating KB801 for ...
About KB801 KB801 is a redosable eye drop gene therapy designed to enable sustained, localized expression and secretion of nerve growth factor (NGF) by epithelial cells in the front of the eye for the ...
KB801 is a redosable eye drop gene therapy in development for the treatment of NK, a degenerative corneal disease characterized by damage or loss of function in the neurons innervating the eye ...
Krystal Biotech climbs after dosing begins in a phase I/II trial for KB801, a gene therapy eye drop targeting neurotrophic keratitis.
Additional exploratory efficacy measures will include change in corneal lesion size from baseline, each assessed at weeks 4, 6, 8, 10, and 20, as well as evaluations of corneal sensation and ...
A 64-year-old woman presented to an outside provider with 5 days of left eye “burning, itching, redness and blurry vision” ...
PITTSBURGH, July 09, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS) announced today that the first patient has been dosed in its Phase 1/2 clinical trial (“EMERALD-1”), ...
Conjunctivitis: Inflammation of the conjunctiva, leading to red, watery eyes. Corneal Ulcers: Damaged cornea that may result from trauma or infection. Cataracts: Clouding of the eye's lens ...
The human eye is a wondrous thing. It is considered the body’s most complex organ after the brain and contains over 2 million working parts. About 80% of all learning happens through vision. So how ...
Gastrointestinal perforation is a serious condition. Discover its causes, symptoms, how it's diagnosed, potential complications, and treatment options.
Looking for the best CBD gummies? We tried CBD gummies from five of the best brands in 2025. Learn more as we break down how well they work and how to find the right gummies for your needs.
Neither corticosteroids nor corneal crosslinking improve outcomes when added to standard bacterial keratitis therapy.